Healthcare -
Biotechnology - NASDAQ - US
$ 2.895
-1.69 %
$ 2.62 M
Market Cap
-0.03
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Revelation Biosciences, Inc.
| Net Income | -15 M |
| Depreciation & Amortization | 27.9 K |
| Capital Expenditures | -19.2 K |
| Stock-Based Compensation | 169 K |
| Change in Working Capital | -3.42 M |
| Others | -2.9 M |
| Free Cash Flow | -18.3 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (15.0) | (0.1) | (10.8) | (12.0) | (1.6) | 3.64 K |
| Depreciation & Amortization | 27.9 K | 25 K | 25 K | 16.8 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.2 | 0.2 | 0.3 | 0.5 | 43.8 K | 0 |
| Other Operating Activities | 56.4 K | (8.3) | 15 K | 52.4 K | 1.5 | 0 |
| Change in Working Capital | (3.4) | 1.0 | (0.7) | 0.4 | 80.5 K | 3.64 K |
| Cash From Operations | (18.3) | (7.3) | (11.2) | (11.1) | (0.2) | 0 |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 19.2 K | 4 | 0 | (0.1) | 0 | 0 |
| Other Items | 0 | 4 | 0 | 0 | (74.0) | 0 |
| Cash From Investing Activities | 19.2 K | 0 | 0 | (0.1) | (74.0) | 0 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 5 K | (7.7) | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (0.8) | 0 | 15 K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7.4 | 4.97 K | 11.5 | 7.4 | (65.4) | 10 K |
| Cash From Financing Activities | 12.8 | 14.0 | 15.2 | 8.0 | 74.3 | 0 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (5.5) | 6.7 | 4.0 | (3.2) | (74.2) | 0 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (18.3) | (7.3) | (11.2) | (11.2) | (0.2) | 0 |